FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308394499> ?p ?o ?g. }

• W4308394499 abstract "<h3>Background</h3> Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease. The five-year survival is only 11%. One hallmark of PDAC is the excessive fibrotic reaction in the tumor microenvironment surrounding the tumor cells. Tumor fibrosis is characterized by an increased activity of fibroblasts and turnover of collagens. Unfortunately, this leads to reduced drug-uptake, impaired immune cell activity and as a result reduced survival in patients. Cytokines in clinical cancer immunotherapy, either as monotherapy or in combination with check-point inhibitors have gained much attention as anti-cancer drugs. Some cytokines have been shown to possess pro- and anti-fibrotic properties and could therefore provide additive value to the anti-cancer efficacy. TGF-β, PDGF-AB, IL-1α, IL-1β, IL-8 and IL-15, are six cytokines highly investigated in clinical trials as monotherapies or in combination with immunotherapies. In this study, we investigated the pro- and anti-fibrotic effects of these cytokines in molecular crowding pancreatic fibroblast culture assays in combination with collagen biomarkers measuring formation of type I, III and VI collagen (PRO-C1, PRO-C3 and PRO-C6, respectively). <h3>Methods</h3> Humane pancreatic fibroblasts were cultured in Ficoll-media. Fibroblasts were treated w/wo TGF-β (1ng/mL), PDGF-AB (100 ng/mL), IL-1α (10 ng/mL), IL-1β (10 ng/mL), IL-8 (10 ng/mL) and IL-15 (10 ng/mL). The fibrotic activity of the fibroblasts was investigated by measuring PRO-C1, PRO-C3 and PRO-C6 in the supernatant at days 3, 6, 9 and 12. Cell-viability was evaluated by Alamar-blue. <h3>Results</h3> The formation of type I collagen (PRO-C1) was significantly increased when fibroblasts were treated with TGF-β, IL-1α and IL-1β, but not PDGF, IL-8 and IL-15 at days 6, 9 and 12. The formation of type III collagen (PRO-C3) was significantly increased when fibroblasts were treated with TGF-β, IL-1α and IL-1β, but not PDGF, IL-8 and IL-15 at days 6, 9, compared to no treatment. At day 12 PRO-C3 was significantly increased in supernatant from fibroblasts treated with TGF-β, IL-1α, IL-1β and IL-8, but not IL-15, compared to no treatment. Interestingly, the formation of type VI collagen (PRO-C6) was only increased when fibroblasts were treated with PDGF-AB compared to no treatment at days 3, 6, 9 and 12. There were no differences in cell viability between treatments. <h3>Conclusions</h3> TGF-β, PDGF-AB, IL-1α, IL-1β, IL-8 and IL-15 have differential effects on the pro-fibrotic activity of pancreatic fibroblasts. This is important knowledge when developing cytokine drugs for clinical cancer immunotherapy trials, suggesting that tumor fibrosis needs to be accounted for when designing and evaluating such studies." @default.
• W4308394499 created "2022-11-11" @default.
• W4308394499 creator A5037705156 @default.
• W4308394499 creator A5049099295 @default.
• W4308394499 creator A5077024175 @default.
• W4308394499 date "2022-11-01" @default.
• W4308394499 modified "2023-09-25" @default.
• W4308394499 title "1422 Cytokines impact fibroblast activity and tumor fibrosis in pancreatic ductal adenocarcinoma" @default.
• W4308394499 doi "https://doi.org/10.1136/jitc-2022-sitc2022.1422" @default.
• W4308394499 hasPublicationYear "2022" @default.
• W4308394499 type Work @default.
• W4308394499 citedByCount "0" @default.
• W4308394499 crossrefType "proceedings-article" @default.
• W4308394499 hasAuthorship W4308394499A5037705156 @default.
• W4308394499 hasAuthorship W4308394499A5049099295 @default.
• W4308394499 hasAuthorship W4308394499A5077024175 @default.
• W4308394499 hasBestOaLocation W43083944991 @default.
• W4308394499 hasConcept C121608353 @default.
• W4308394499 hasConcept C126322002 @default.
• W4308394499 hasConcept C142724271 @default.
• W4308394499 hasConcept C203014093 @default.
• W4308394499 hasConcept C2776107976 @default.
• W4308394499 hasConcept C2777701055 @default.
• W4308394499 hasConcept C2778690821 @default.
• W4308394499 hasConcept C2780210213 @default.
• W4308394499 hasConcept C2780381497 @default.
• W4308394499 hasConcept C2780559512 @default.
• W4308394499 hasConcept C2781182431 @default.
• W4308394499 hasConcept C2909706936 @default.
• W4308394499 hasConcept C502942594 @default.
• W4308394499 hasConcept C54355233 @default.
• W4308394499 hasConcept C71924100 @default.
• W4308394499 hasConcept C81885089 @default.
• W4308394499 hasConcept C86803240 @default.
• W4308394499 hasConcept C8891405 @default.
• W4308394499 hasConceptScore W4308394499C121608353 @default.
• W4308394499 hasConceptScore W4308394499C126322002 @default.
• W4308394499 hasConceptScore W4308394499C142724271 @default.
• W4308394499 hasConceptScore W4308394499C203014093 @default.
• W4308394499 hasConceptScore W4308394499C2776107976 @default.
• W4308394499 hasConceptScore W4308394499C2777701055 @default.
• W4308394499 hasConceptScore W4308394499C2778690821 @default.
• W4308394499 hasConceptScore W4308394499C2780210213 @default.
• W4308394499 hasConceptScore W4308394499C2780381497 @default.
• W4308394499 hasConceptScore W4308394499C2780559512 @default.
• W4308394499 hasConceptScore W4308394499C2781182431 @default.
• W4308394499 hasConceptScore W4308394499C2909706936 @default.
• W4308394499 hasConceptScore W4308394499C502942594 @default.
• W4308394499 hasConceptScore W4308394499C54355233 @default.
• W4308394499 hasConceptScore W4308394499C71924100 @default.
• W4308394499 hasConceptScore W4308394499C81885089 @default.
• W4308394499 hasConceptScore W4308394499C86803240 @default.
• W4308394499 hasConceptScore W4308394499C8891405 @default.
• W4308394499 hasLocation W43083944991 @default.
• W4308394499 hasOpenAccess W4308394499 @default.
• W4308394499 hasPrimaryLocation W43083944991 @default.
• W4308394499 hasRelatedWork W3028822667 @default.
• W4308394499 hasRelatedWork W3127386268 @default.
• W4308394499 hasRelatedWork W3202266063 @default.
• W4308394499 hasRelatedWork W4286250285 @default.
• W4308394499 hasRelatedWork W4287578465 @default.
• W4308394499 hasRelatedWork W4313505516 @default.
• W4308394499 hasRelatedWork W4361288676 @default.
• W4308394499 hasRelatedWork W4361896681 @default.
• W4308394499 hasRelatedWork W4361896768 @default.
• W4308394499 hasRelatedWork W4362594752 @default.
• W4308394499 isParatext "false" @default.
• W4308394499 isRetracted "false" @default.
• W4308394499 workType "article" @default.